MapLight Therapeutics

MPLT · NASDAQ

$8.24+$0.24 (+3.00%)TodayMarket closed ·
Prev close $8.00

Who owns MPLT

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 87.3% of MPLT’s shares.

  • Catalyst4 Inc55.8%
  • Forbion Capital Partners7.1%
  • T. Rowe Price Investment Management, Inc.6.1%
  • Novo Holdings A/S4.6%
  • Next 6 largest institutions13.7%
  • All other shareholders12.7%
Top institutional holders of MPLT
HolderShares% of shares
Catalyst4 Inc25.31M55.80%
Forbion Capital Partners3.23M7.11%
T. Rowe Price Investment Management, Inc.2.78M6.13%
Novo Holdings A/S2.09M4.60%
T. Rowe Price Associates, Inc.1.41M3.12%
Goldman Sachs & Co. LLC1.08M2.39%
Nan Fung Life Sciences971.25K2.14%
5AM Ventures950.01K2.09%
Sanofi SA912.04K2.01%
Goldman Sachs Asset Management, L.P.865.74K1.91%

Largest mutual fund holders

Top mutual fund holders of MPLT
HolderShares% of shares
T. Rowe Price Small Cap Stock Fund625.05K1.38%
T. Rowe Price Small Cap Value Fund605.60K1.34%
Vanguard Total Stock Market Index Fund552.28K1.22%
State Street SPDR S&P Biotech ETF526.06K1.16%
American Funds SMALLCAP World Fund404.39K0.89%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $98.86M (7 trades) and sold $27.60M (114 trades) of MPLT on the open market.

Latest MPLT insider transactions
InsiderTypeSharesValue
Kreitzer AnatolSale12.25K$96.02K
Foff Erin PennockSale15.36K$124.07K
Hanson KristopherSale9.02K$72.88K
Lillie James WoodruffSale11.51K$93.03K
GILLIS JONATHANSale10.17K$82.15K
Kroeger Christopher A.Sale73.69K$595.42K
Hanson KristopherSale16.51K$192.66K
Kreitzer AnatolAward24.45K—
Kreitzer AnatolAward6.02K—
Foff Erin PennockAward54.24K—

Short interest

Settled Sep 30, 2026

Shares short
3.15M
Days to cover
5.80
% of shares outstanding
6.94%
Average daily volume
542.98K
Change since last report
−4.5%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.